![]() 002038 In 11 months Estimated | Annual | ¥0.02 Per Share |
![]() 002038 3 weeks ago Paid | Annual | ¥0.02 Per Share |
![]() 002038 4 Jul 2024 | Other | ¥0.15 Per Share |
![]() 002038 28 Jun 2023 | Other | ¥0.1 Per Share |
![]() 002038 29 Jun 2022 | Other | ¥0.1 Per Share |
![]() 002038 7 Jul 2021 | Other | ¥0.1 Per Share |
26 Oct 2024 Date | | - Cons. EPS | - EPS |
26 Aug 2024 Date | | - Cons. EPS | - EPS |
23 May 2024 Date | | - Cons. EPS | 0.07 EPS |
24 Apr 2024 Date | | - Cons. EPS | 0.07 EPS |
26 Oct 2023 Date | | - Cons. EPS | 0 EPS |
![]() 002038 In 11 months Estimated | Annual | ¥0.02 Per Share |
![]() 002038 3 weeks ago Paid | Annual | ¥0.02 Per Share |
![]() 002038 4 Jul 2024 | Other | ¥0.15 Per Share |
![]() 002038 28 Jun 2023 | Other | ¥0.1 Per Share |
![]() 002038 29 Jun 2022 | Other | ¥0.1 Per Share |
![]() 002038 7 Jul 2021 | Other | ¥0.1 Per Share |
26 Oct 2024 Date | | - Cons. EPS | - EPS |
26 Aug 2024 Date | | - Cons. EPS | - EPS |
23 May 2024 Date | | - Cons. EPS | 0.07 EPS |
24 Apr 2024 Date | | - Cons. EPS | 0.07 EPS |
26 Oct 2023 Date | | - Cons. EPS | 0 EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Dr. Mingbo Xu Ph.D. CEO | XSHE Exchange | CNE000001L31 ISIN |
CN Country | 889 Employees | - Last Dividend | 4 Jul 2019 Last Split | 25 Aug 2004 IPO Date |
Beijing SL Pharmaceutical Co., Ltd., established in 1994 under its former name Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd., and underwent a name change in 1998 to its current designation. Operating from the heart of Beijing, in the People’s Republic of China, this biopharmaceutical entity engages profoundly in the realms of research, development, production, and international marketing of genetic engineering drugs and its related products. Serving not only the domestic market of China but also catering to international demands, the company has established itself as a significant player in the biopharmaceutical sector.
Beijing SL Pharmaceutical Co., Ltd. offers a comprehensive range of formulations and active pharmaceutical ingredients (APIs), catering to various therapeutic areas:
Apart from finished formulations, Beijing SL Pharmaceutical Co., Ltd. also specializes in the production of high-quality active pharmaceutical ingredients (APIs), thereby contributing vitally to the pharmaceutical industry's supply chain both domestically and internationally.